Agilent Technologies, Inc. (Symbol: A) – Monthly Stock Report
Publication Date: September 22, 2024
Company Overview
Agilent Technologies, Inc., headquartered in Santa Clara, California, is a prominent player in the healthcare sector, focusing primarily on diagnostics and research. Founded in 1999, Agilent offers application-centric solutions across life sciences, diagnostics, and applied chemical markets. The company’s operations are divided into three main segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. Their extensive product lineup includes liquid and gas chromatography systems, mass spectrometry instruments, and laboratory automation tools tailored to the needs of researchers and clinical professionals. With a current recommendation to buy, analysts are optimistic about Agilent’s growth potential, setting a target high price of $165.00 per share and reporting total revenue of approximately $6.50 billion.
Stock Performance & Market Sentiment
Agilent’s stock currently trades at $140.09, with analysts projecting a mean target price of $146.04, indicating a positive outlook for value appreciation. The target high price stands at $165.00, while the target low price is identified at $130.00, suggesting a robust performance range. The stock’s fifty-day moving average is recorded at 137.66, signaling that the current trading price is above this trendline, reflecting bullish investor sentiment. Additionally, the stock has shown impressive resilience over the past year, with a fifty-two week high of $155.35 and a low of $96.80, currently positioned 2.4% beneath its year-high and a remarkable 44.5% above its year-low.
Short Interest Analysis
Agilent Technologies possesses 287,328,000 shares outstanding, with a short interest level of approximately 0.0124%, indicating limited bearish sentiment among investors. Of the total float, 3,160,001 shares are currently sold short, reflecting a stable market outlook for Agilent’s stock. This low short interest suggests that fear of a downturn is minimal, further corroborating the overall positive recommendations and potential for future growth. Moreover, the consensus mean recommendation score of 2.5 from 16 analysts reinforces the sentiment that investors are leaning towards acquiring shares, aiming for anticipated gains in the near future.
Overall, Agilent Technologies remains an attractive option for investors, highlighted by consistent revenue streams and favorable market positioning.
| Metric | Value |
|---|---|
| Market Cap | $40.3b |
| Total Debt | $3.1b |
| Total Cash | $1.8b |
| Shares Outstanding | 287.3m |
| Float Shares | 286.2m |
Disclaimer:
The information provided in this monthly report is for informational purposes only and should not be construed as financial, investment, or trading advice. AltStation.io does not guarantee the accuracy, completeness, or timeliness of the data and analyses presented. The content is based on publicly available information, and while we strive to ensure its accuracy, errors and omissions may occur.
Investing in stocks, cryptocurrencies, and other financial instruments involves significant risk, including the potential loss of principal. Past performance is not indicative of future results. Readers should conduct their own research and consult with a qualified financial advisor before making any investment decisions. AltStation.io and its affiliates are not responsible for any losses incurred as a result of using this report.
By using this report, you acknowledge that you understand and accept these terms.